Q SYNTHESIS LLC
  • Quality Improvement
  • Systems Thinking
  • Implementation Science
  • Publications
  • About
  • Contact
  • Updates

ASCP Pathology Trailblazers in HER2-low Breast Cancer

3/10/2022

 
ASCP, working in collaboration with Q Synthesis LLC, invites pathologists to participate in a unique cohort-based leadership development CME program called Pathology Trailblazers: HER2-low Breast Cancer Collaborative Learning Exchange.

This program will begin in May 2022 and run for approximately 3 months. 

Pathology Trailblazers: HER2-low Breast Cancer Collaborative Learning Exchange is designed to:
  • Strengthen leadership skills among pathologists
  • Increase knowledge and competence around the evolving landscape of HER2-low breast cancer
  • Improve how HER2 testing is performed, classified, and reported
  • Support the dissemination and implementation of best practices around HER2 testing and reporting in breast cancer

Learn more about this unique program here: ​https://www.ascp.org/content/learning/breast-cancer#trailblazers


Comments are closed.

    Author

    @DrJosephKim
    Joseph Kim, MD, MPH, MBA, FACEHP is the Founder and President of Q Synthesis LLC.

    ​View Dr. Kim's bio on LinkedIn. 

    ​


    Sign up to receive updates:
Q Synthesis LLC
Home

About

Contact
​

​Publications
Picture
​Quality Improvement 
​
Systems Thinking 

​Implementation Science 

​Updates
www.qsynthesis.com
  • Quality Improvement
  • Systems Thinking
  • Implementation Science
  • Publications
  • About
  • Contact
  • Updates